Use of Continuous Intravenous Anakinra Infusion in Multisystem Inflammatory Syndrome in Children
Coronavirus disease (COVID-19) is an emergency pandemic with a high mortality rate worldwide. One of its complications in children is developing multisystemic inflammatory syndrome related to cytokine storm. Anakinra is a recombinant human interleukin-1 (IL-1) receptor antagonist used to suppress th...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Case Reports in Critical Care |
Online Access: | http://dx.doi.org/10.1155/2023/8530060 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832559270141362176 |
---|---|
author | Abdulaziz Alolayan Abdullah S. Aldamegh Azzah Alkhayrat |
author_facet | Abdulaziz Alolayan Abdullah S. Aldamegh Azzah Alkhayrat |
author_sort | Abdulaziz Alolayan |
collection | DOAJ |
description | Coronavirus disease (COVID-19) is an emergency pandemic with a high mortality rate worldwide. One of its complications in children is developing multisystemic inflammatory syndrome related to cytokine storm. Anakinra is a recombinant human interleukin-1 (IL-1) receptor antagonist used to suppress the exaggerated inflammatory response in such conditions, and it is potentially lifesaving in a cytokine storm. We present the case of a patient with critical COVID-19 associated with multisystem inflammatory syndrome in children (MIS-C) successfully treated with anakinra intravenous (IV) infusion. |
format | Article |
id | doaj-art-3cff685e1af24152a32dc350f96b0ba0 |
institution | Kabale University |
issn | 2090-6439 |
language | English |
publishDate | 2023-01-01 |
publisher | Wiley |
record_format | Article |
series | Case Reports in Critical Care |
spelling | doaj-art-3cff685e1af24152a32dc350f96b0ba02025-02-03T01:30:25ZengWileyCase Reports in Critical Care2090-64392023-01-01202310.1155/2023/8530060Use of Continuous Intravenous Anakinra Infusion in Multisystem Inflammatory Syndrome in ChildrenAbdulaziz Alolayan0Abdullah S. Aldamegh1Azzah Alkhayrat2Pharmacy DepartmentPediatrics DepartmentPharmacy DepartmentCoronavirus disease (COVID-19) is an emergency pandemic with a high mortality rate worldwide. One of its complications in children is developing multisystemic inflammatory syndrome related to cytokine storm. Anakinra is a recombinant human interleukin-1 (IL-1) receptor antagonist used to suppress the exaggerated inflammatory response in such conditions, and it is potentially lifesaving in a cytokine storm. We present the case of a patient with critical COVID-19 associated with multisystem inflammatory syndrome in children (MIS-C) successfully treated with anakinra intravenous (IV) infusion.http://dx.doi.org/10.1155/2023/8530060 |
spellingShingle | Abdulaziz Alolayan Abdullah S. Aldamegh Azzah Alkhayrat Use of Continuous Intravenous Anakinra Infusion in Multisystem Inflammatory Syndrome in Children Case Reports in Critical Care |
title | Use of Continuous Intravenous Anakinra Infusion in Multisystem Inflammatory Syndrome in Children |
title_full | Use of Continuous Intravenous Anakinra Infusion in Multisystem Inflammatory Syndrome in Children |
title_fullStr | Use of Continuous Intravenous Anakinra Infusion in Multisystem Inflammatory Syndrome in Children |
title_full_unstemmed | Use of Continuous Intravenous Anakinra Infusion in Multisystem Inflammatory Syndrome in Children |
title_short | Use of Continuous Intravenous Anakinra Infusion in Multisystem Inflammatory Syndrome in Children |
title_sort | use of continuous intravenous anakinra infusion in multisystem inflammatory syndrome in children |
url | http://dx.doi.org/10.1155/2023/8530060 |
work_keys_str_mv | AT abdulazizalolayan useofcontinuousintravenousanakinrainfusioninmultisysteminflammatorysyndromeinchildren AT abdullahsaldamegh useofcontinuousintravenousanakinrainfusioninmultisysteminflammatorysyndromeinchildren AT azzahalkhayrat useofcontinuousintravenousanakinrainfusioninmultisysteminflammatorysyndromeinchildren |